The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 1, 2010, Pages 7-15

  Young, Jared W ^a   Goey, Andrew K L ^b   Minassian, Arpi ^a   Perry, William ^a   Paulus, Martin P ^a,c   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Behavioral Pattern Monitor; Bipolar Disorder; Dopamine transporter; GBR 12909; Mania; Mice; Model

Indexed keywords

DOPAMINE TRANSPORTER; PSYCHOSTIMULANT AGENT; VANOXERINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; ENVIRONMENTAL FACTOR; EXPLORATORY BEHAVIOR; FEMALE; LOCOMOTION; MALE; MANIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BLOCKING; WILD TYPE;

ANIMALS; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENVIRONMENT; EXPLORATORY BEHAVIOR; GENE KNOCKDOWN TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MOTOR ACTIVITY; RECOGNITION (PSYCHOLOGY);

ANIMALIA; MUS;

EID: 77953285045     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.03.014     Document Type: Article

References (51)

1. Adida M., Clark L., Pomietto P., Kaladjian A., Besnier N., Azorin J.M., et al. Lack of insight may predict impaired decision making in manic patients. Bipolar Disord 2008, 10:829-837.
2. Amsterdam J.D., Newberg A.B. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology 2007, 55:167-170.
3. Benedetti F., Serretti A., Colombo C., Barbini B., Lorenzi C., Campori E., et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2003, 123B:23-26.
4. Cagniard B., Balsam P.D., Brunner D., Zhuang X. Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacology 2006, 31:1362-1370.
5. Clark L., Iversen S.D., Goodwin G.M. A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry 2001, 158:1605-1611.
6. Coyle J.T. What can a clock mutation in mice tell us about bipolar disorder?. Proc Natl Acad Sci U S A 2007, 104:6097-6098.
7. Davies C., Sanger D.J., Steinberg H., Tomkiewicz M., U'Prichard D.C. Lithium and alpha-methyl-p-tyrosine prevent "manic" activity in rodents. Psychopharmacologia 1974, 36:263-274.
8. Ehlers C.L., Frank E., Kupfer D.J. Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression. Arch Gen Psychiatry 1988, 45:948-952.
9. Einat H. Modelling facets of mania-new directions related to the notion of endophenotypes. J Psychopharmacol (Oxford, England) 2006, 20:714-722.
10. File S.E., Wardill A.G. Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia 1975, 44:53-59.
11. Flicker C., Geyer M.A. Behavior during hippocampal microinfusions. I. Norepinephrine and diversive exploration. Brain Res 1982, 257:79-103.
12. Frangou S., Kington J., Raymont V., Shergill S.S. Examining ventral and dorsal prefrontal function in bipolar disorder: a functional magnetic resonance imaging study. Eur Psychiatry 2008, 23:300-308.
13. Frank E., Kupfer D.J., Thase M.E., Mallinger A.G., Swartz H.A., Fagiolini A.M., et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry 2005, 62:996-1004.
14. Gainetdinov R.R., Jones S.R., Caron M.G. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry 1999, 46:303-311.
15. Geyer M.A., Russo P.V., Masten V.L. Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol Biochem Behav 1986, 25:277-288.
16. Gould T.D., Einat H. Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement. Neurosci Biobehav Rev 2007, 31:825-831.
17. Greenwood T.A., Alexander M., Keck P.E., McElroy S., Sadovnick A.D., Remick R.A., et al. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 2001, 105:145-151.
18. Greenwood TA, Schork NJ, Eskin E, Kelsoe JR. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Molecular psychiatry. 2006;11:125-33, 15.
19. Gulley J.M., Everett C.V., Zahniser N.R. Inbred Lewis and Fischer 344 rat strains differ not only in novelty- and amphetamine-induced behaviors, but also in dopamine transporter activity in vivo. Brain Res 2007, 1151:32-45.
20. Halberstadt A.L., van der Heijden I., Ruderman M.A., Risbrough V.B., Gingrich J.A., Geyer M.A., et al. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology 2009, 34:1958-1967.
21. Heikkila R.E., Manzino L. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. Eur J Pharmacol 1984, 103:241-248.
22. Hewitt K.N., Marsden C.A., Hollis C.P., Fone K.C. Behavioural characterisation of the effects of acute and repeated administration of GBR 12909 in rats: further evaluation of a potential model of ADHD. Neuropharmacology 2009, 57:678-686.
23. Horschitz S., Hummerich R., Lau T., Rietschel M., Schloss P. A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression. Mol Psychiatry 2005, 10:1104-1109.
24. Kelsoe J.R., Sadovnick A.D., Kristbjarnarson H., Bergesch P., Mroczkowski-Parker Z., Drennan M., et al. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet 1996, 67:533-540.
25. Kliethermes C.L., Crabbe J.C. Pharmacological and genetic influences on hole-board behaviors in mice. Pharmacol Biochem Behav 2006, 85:57-65.
26. Kozikowski A.P., Gaisina I.N., Yuan H., Petukhov P.A., Blond S.Y., Fedolak A., et al. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. Possible new GSK-3beta therapies for bipolar disorders. J Am Chem Soc 2007, 129:8328-8332.
27. Krause K.H., Dresel S.H., Krause J., la Fougere C., Ackenheil M. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci Biobehav Rev 2003, 27:605-613.
28. Lake C.R., Tenglin R., Chernow B., Holloway H.C. Psychomotor stimulant-induced mania in a genetically predisposed patient: a review of the literature and report of a case. J Clin Psychopharmacol 1983, 3:97-100.
29. Le-Niculescu H., Patel S.D., Bhat M., Kuczenski R., Faraone S.V., Tsuang M.T., et al. Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:155-181.
30. Legault M., Wise R.A. Novelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area. Eur J Neurosci 2001, 13:819-828.
31. MacQueen G.M., Hajek T., Alda M. The phenotypes of bipolar disorder: relevance for genetic investigations. Mol Psychiatry 2005, 10:811-826.
32. Madras B.K., Miller G.M., Fischman A.J. The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). Behav Brain Res 2002, 130:57-63.
33. Malkoff-Schwartz S., Frank E., Anderson B., Sherrill J.T., Siegel L., Patterson D., et al. Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: a preliminary investigation. Arch Gen Psychiatry 1998, 55:702-707.
34. Malkoff-Schwartz S., Frank E., Anderson B.P., Hlastala S.A., Luther J.F., Sherrill J.T., et al. Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychol Med 2000, 30:1005-1016.
35. Paulus M.P., Geyer M.A. A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology 1991, 104:6-16.
36. Perry W., Minassian A., Paulus M.P., Young J.W., Kincaid M.J., Ferguson E.J., et al. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry 2009, 66:1072-1080.
37. Post R.M. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev 2007, 31:858-873.
38. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 2006, 26:9022-9029.
39. Randrup A., Munkvad I. Pharmacology and physiology of stereotyped behavior. J Psychiatr Res 1974, 11:1-10.
40. Risbrough V.B., Masten V.L., Caldwell S., Paulus M.P., Low M.J., Geyer M.A. Differential contributions of dopamine D(1), D(2), and D(3) receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology 2006, 31:2349-2358.
41. Roybal K., Theobold D., Graham A., DiNieri J.A., Russo S.J., Krishnan V., et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A 2007, 104:6406-6411.
42. Rushton R., Steinberg H. Dose-response relations of amphetamine-barbiturate mixtures. Nature 1963, 197:1017-1018.
43. Sylvia L.G., Alloy L.B., Hafner J.A., Gauger M.C., Verdon K., Abramson L.Y. Life events and social rhythms in bipolar spectrum disorders: a prospective study. Behav Ther 2009, 40:131-141.
44. Tilley M.R., Cagniard B., Zhuang X., Han D.D., Tiao N., Gu H.H. Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression. BMC Neurosci 2007, 8:42.
45. Wingo A.P., Ghaemi S.N. Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patients. Psychopharmacol Bull 2008, 41:37-47.
46. Young J.W., Geyer M.A. Action of modafinil-increased motivation via the dopamine transporter inhibition and D1 receptors?. Biological Psychiatry 2010, 67(8):784-787.
47. Young J.W., Minassian A., Paulus M.P., Geyer M.A., Perry W. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci Biobehav Rev 2007, 31:882-896.
48. Young J.W., Goey A.K., Minassian A., Perry W., Paulus M.P., Geyer M.A. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology 2010, 208(3):443-454.
49. Zalcman S.S. Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity. Brain Res 2001, 899:1-9.
50. Zhu J., Bardo M.T., Bruntz R.C., Stairs D.J., Dwoskin L.P. Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression. Eur J Neurosci 2007, 26:717-728.
51. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci U S A 2001, 98:1982-1987.